Photodynamic inactivation of prions by disulfonated hydroxyaluminium phthalocyanine.

J Gen Virol

Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University in Prague, Studnickova 7, 128 00 Prague 2, Czech Republic.

Published: November 2012

Sulfonated phthalocyanines (Pcs) are cyclic tetrapyrroles that constitute a group of photosensitizers. In the presence of visible light and diatomic oxygen, Pcs produce singlet oxygen and other reactive oxygen species that have known degradation effects on lipids, proteins and/or nucleic acids. Pcs have been used successfully in the treatment of bacterial, yeast and fungal infections, but their use in the photodynamic inactivation of prions has never been reported. Here, we evaluated the photodynamic activity of the disodium salt of disulfonated hydroxyaluminium phthalocyanine (PcDS) against mouse-adapted scrapie RML prions in vitro. PcDS treatment of RML brain homogenate resulted in a time- and dose-dependent inactivation of prions. The photodynamic potential of Pcs offers a new way to inactivate prions using biodegradable compounds at room temperature and normal pressure, which could be useful for treating thermolabile materials and liquids.

Download full-text PDF

Source
http://dx.doi.org/10.1099/vir.0.044727-0DOI Listing

Publication Analysis

Top Keywords

inactivation prions
12
photodynamic inactivation
8
disulfonated hydroxyaluminium
8
hydroxyaluminium phthalocyanine
8
prions
5
photodynamic
4
prions disulfonated
4
phthalocyanine sulfonated
4
sulfonated phthalocyanines
4
pcs
4

Similar Publications

Prion Safety Laboratory Swipe Test.

J Vis Exp

February 2025

Department of Medical Microbiology and Immunology, School of Medicine, Creighton University;

Transmission of iatrogenic prion disease has occurred from contaminated neurosurgical tools, transplant materials, and occupational exposure to prion-contaminated laboratory tools. Prions cause disease by the templated misfolding of the normal cellular form of the prion protein, PrP, into the misfolded and pathogenic form PrP and are invariably fatal. Reducing iatrogenic and occupational prion transmission is challenging.

View Article and Find Full Text PDF

A new alternative method for the processing of entire bodies or body parts of pet animals (Category 1 animal by-products (ABPs)) was assessed. The method consists of an alkaline hydrolysis process under atmospheric pressure carried out in a batch system within a stainless-steel container at temperatures higher than 95.5°C for more than 14 h.

View Article and Find Full Text PDF

Optimization and evaluation of new decontamination procedures inactivating human prions.

J Hosp Infect

February 2025

Molecular Virology Immunology (VIM) Unit, Université Paris-Saclay, INRAE, UVSQ, Jouy-en-Josas, France; FB.Product, Torcé viviers en charnie, France. Electronic address:

Background: Prions are protein-only infectious agents for which no prophylactic or curative treatment exists. Infectivity bioassays based on hamster-263K prions allowed to identify processes capable of inactivating prions on medical devices. However, a 2016 publication study revealed that detergent formulations effective against hamster strain had poor efficacy against human strains.

View Article and Find Full Text PDF

Amyloid-β (Aβ) aggregates accumulate in the brains of individuals with Alzheimer's disease and are thought to potentially act as prions, promoting further aggregation. Consequently, the biochemistry of Aβ has emerged as a promising target for Alzheimer's disease. CAC-717, a suspension of calcium bicarbonate mesoscopic structures derived from natural sources, has been shown to inactivate various pathogens, including prions.

View Article and Find Full Text PDF

Influenza A viruses (IAV) of subtypes H1N1, H1N2, and H3N2 are endemic in US domestic swine populations and contribute to significant economic losses annually and pose a persistent pandemic threat. Adjuvanted, whole-inactivated virus (WIV) vaccines are the primary countermeasure to control IAV in swine. The compositions of these vaccines are matched for hemagglutinin (HA) strain and content, often ignoring the other IAV glycoprotein, the neuraminidase (NA).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!